Skip to Primary Navigation Skip to Site Navigation Skip to Main Content All 3M.com Site Map

Licensing-ready Innovations that Expand Your Portfolio

Whether you want to break into a new market or add new products to your current portfolio, partner with 3M Drug Delivery Systems on
innovations that are ready to license today.

Licensing Opportunities

Ready to license fentanyl and rivastigmine 
generic patches from 3M

Transdermal Patches

Ready to license fentanyl and rivastigmine generic patches from 3M give you the chance to expand into a growing transdermal generic market. These unique licensing opportunities expand your portfolio while increasing speed to market.

Ready to license TLR agonists from 3M

TLR Agonists

3M offers a portfolio of license-ready toll-like receptor (TLR) agonists at various stages of development. Unlike most other TLR agonists, our molecules are small, easy to manufacture, stable and can be delivered by multiple routes of administration. These molecules could be used as single agents for cancer, for dermatology and asthma allergy treatment, or in combination with vaccines.


Content Divide

Contact Us

Contact 3M Drug Delivery Systems Partner with a Global Leader
Talk to your local 3M representative about expanding your portfolio with license-ready products from a company you can trust.

Contact Us

3M development and manufacturing services

Follow Us

linkedin icon image Youtube icon image